Local Control After Robot-assisted Supraglottic Laryngectomy

Completed

• Conditions: Supraglottic Squamous Cell Carcinoma

• Registration Number: NCT03357107
• Lead Sponsor: Hospices Civils de Lyon

Brief Summary

Transoral robotic surgery is an option to treat supraglottic squamous cell carcinomas. Oncological outcomes 2 years after transoral robotic surgery for supraglottic laryngectomy were studied.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-10-01
• Primary Completion: 2017-02-28
• Study Completion: 2017-02-28
• Status Verified: 2017-11
• Study First Submitted: 2017-11-23
• Study First Submitted QC: 2017-11-23
• Study First Posted: 2017-11-29
• Last Update Submitted: 2017-11-29
• Last Update Posted: 2017-11-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 122

Inclusion Criteria

• Men or women over 18 years of age
• Patients with supra-glottic squamous cell carcinoma from T1 to T3, all stages N
• Patients with a robot assisted supra-glottic laryngectomy with at least 2 years follow-up

Read More

Exclusion Criteria

• Patients for whom follow-up of at least 2 years has not been achieved;
• Major patients protected by the law (under guardianship or guardianship);
• Patients who expressed opposition to their participation in the study.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Local control	2 years after surgery	Proportion of patients without cancer recurrence 2 years after surgery

Trial Locations

Locations (1)

Croix-Rousse Hospital, Hospices Civils de Lyon; 🇫🇷 Lyon, France